SURGICAL SCAFFOLD
Device
Allergan Inc.
Total Payments
$153,371
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $153,371 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $153,371 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A SERI Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair | Allergan Inc. | $99,446 | 0 |
| SERI SURGICAL SCAFFOLD SUPPORT OF THE LOWER POLE OF THE BREAST IN MASTOPEXY WITH AUGMENTATION PATIENTS | Allergan Inc. | $53,925 | 0 |
Top Doctors Receiving Payments for SURGICAL SCAFFOLD
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Lexington, KY | $153,371 | 2 |
Ad
Manufacturing Companies
- Allergan Inc. $153,371
Product Information
- Type Device
- Total Payments $153,371
- Total Doctors 0
- Transactions 2
About SURGICAL SCAFFOLD
SURGICAL SCAFFOLD is a device associated with $153,371 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..
Payment data is available from 2017 to 2017. In 2017, $153,371 was paid across 2 transactions to 0 doctors.
The most common payment nature for SURGICAL SCAFFOLD is "Unspecified" ($153,371, 100.0% of total).
SURGICAL SCAFFOLD is associated with 2 research studies, including "A SERI Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair" ($99,446).